Life ScienceCompany
Chroma Therapeutics - Esterase Sensitive Motif Ownership
Who owns Chroma Therapeutics - Esterase Sensitive Motif?
Chroma Therapeutics - Esterase Sensitive Motif is owned by Macrophage Pharma. It was acquired on January 9, 2017.
Chroma Therapeutics - Esterase Sensitive Motif Business Overview
Where is Chroma Therapeutics - Esterase Sensitive Motif headquartered?
Chroma Therapeutics - Esterase Sensitive Motif is headquartered in Abingdon, United Kingdom.
What sector is Chroma Therapeutics - Esterase Sensitive Motif in?
Chroma Therapeutics - Esterase Sensitive Motif is a life science company.
Life Science M&A Summary in 2017
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.
Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.